Sign In
Buy RMD
$188.63
+2.34 (+1.26%)
At Close: Jun 18, 2026
Top Research Reports for Chevron, Novo Nordisk & Amgen
04:10pm, Tuesday, 14'th Feb 2023 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including Chevron Corporation (CVX), Novo Nordisk A/S (NVO) and Amgen Inc. (AMGN).
ResMed's (RMD) Mask Sales Drive Growth, Margin Issue Lingers
02:32pm, Tuesday, 14'th Feb 2023 Zacks Investment Research
ResMed (RMD) continues to see robust demand for its market-leading mask portfolio despite being faced with challenges related to lower new patient setups from a competitor recall.
ResMed's (RMD) Mask Sales Drive Growth, Margin Issue Lingers
11:18am, Tuesday, 14'th Feb 2023
ResMed (RMD) continues to see robust demand for its market-leading mask portfolio despite being faced with challenges related to lower new patient setups from a competitor recall.
ResMed: Bulls Can Rest For Now, For Its Declining Cash Flow Performance
03:08pm, Monday, 30'th Jan 2023
ResMed continues to be a leading company in the industry, with multiple growth drivers ahead of its 2025 goals. But the outlook for ResMed doesn't look good, with YoY figures slowing and dividend paym
ESLOY vs. RMD: Which Stock Is the Better Value Option?
04:40pm, Friday, 27'th Jan 2023 Zacks Investment Research
ESLOY vs. RMD: Which Stock Is the Better Value Option?
ResMed's (RMD) Q2 Earnings Beat Estimates, Margins Falls
03:40pm, Friday, 27'th Jan 2023 Zacks Investment Research
ResMed's (RMD) mask sales growth was strong across the globe, reflecting a post-COVID pandemic awareness about the importance and need for respiratory hygiene and respiratory health.
ESLOY vs. RMD: Which Stock Is the Better Value Option?
12:47pm, Friday, 27'th Jan 2023
ESLOY vs. RMD: Which Stock Is the Better Value Option?
ResMed's (RMD) Q2 Earnings Beat Estimates, Margins Falls
12:02pm, Friday, 27'th Jan 2023
ResMed's (RMD) mask sales growth was strong across the globe, reflecting a post-COVID pandemic awareness about the importance and need for respiratory hygiene and respiratory health.
ResMed (RMD) Q2 Earnings and Revenues Surpass Estimates
10:25pm, Thursday, 26'th Jan 2023 Zacks Investment Research
ResMed (RMD) delivered earnings and revenue surprises of 3.75% and 3.64%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
ResMed Inc. (RMD) Q2 2023 Earnings Call Transcript
09:33pm, Thursday, 26'th Jan 2023
ResMed Inc. (NYSE:RMD ) Q2 2023 Earnings Conference Call January 26, 2023 4:30 PM ET Company Participants Amy Wakeham - VP, IR & Corporate Communications Mick Farrell - CEO and Chairman Brett Sanderco
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2023
09:05pm, Thursday, 26'th Jan 2023 GlobeNewswire Inc.
Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com
ResMed Appoints Michael Farrell as Chair of its Board of Directors Peter Farrell to Become Chair Emeritus
09:05pm, Thursday, 26'th Jan 2023 GlobeNewswire Inc.
SAN DIEGO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced ResMed’s board of directors has appointed chief executive officer Michael (“Mick”) Farrell as chair of
ResMed (RMD) Q2 Earnings and Revenues Surpass Estimates
06:48pm, Thursday, 26'th Jan 2023
ResMed (RMD) delivered earnings and revenue surprises of 3.75% and 3.64%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Wall Street Breakfast: What Moved Markets
01:31pm, Saturday, 21'st Jan 2023 Seeking Alpha
Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify.
Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023
03:01pm, Tuesday, 17'th Jan 2023 Benzinga
Upgrades
For Casa Systems Inc (NASDAQ:CASA), Northland Capital Markets upgraded the previous rating of Market Perform to Outperform. Casa Systems earned $0.29 in the third quarter, compared to $0.05 i
